ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Burza S, Croft SL, Boelaert M, 2018. Leishmaniasis. Lancet 392: 951–970.
-
2.
Hashiguchi Y, Gomez EL, Kato H, Martini LR, Velez LN, Uezato H, 2016. Diffuse and disseminated cutaneous leishmaniasis: clinical cases experienced in Ecuador and a brief review. Trop Med Health 44: 2.
-
3.
Eiras DP, Kirkman LA, Murray HW, 2015. Cutaneous leishmaniasis: current treatment practices in the USA for returning travelers. Curr Treat Options Infect Dis 7: 52–62.
-
4.
Goto H, Lauletta Lindoso JA, 2012. Cutaneous and mucocutaneous leishmaniasis. Infect Dis Clin North Am 26: 293–307.
-
5.
Kumari A, Balai M, Gupta LK, Khare AK, Mittal AK, Mehta S, 2018. Diffuse cutaneous leishmaniasis in an immunocompromised patient resembling histoid Hansen’s disease. Indian Dermatol Online J 9: 452–454.
-
6.
Mariz BALA, Sánchez-Romero C, Alvarado NAP, Campos EMM, Almeida OP, MartÃnez-Pedraza R, 2019. Diffuse cutaneous leishmaniasis with oral involvement in a patient of Northern Mexico. Trop Doct 49: 303–306.
-
7.
Rahman H, Razzak MA, Chanda BC, Bhaskar KR, Mondal D, 2014. Cutaneous leishmaniasis in an immigrant Saudi worker: a case report. J Health Popul Nutr 32: 372–376.
-
8.
Suzanne A, Grevelink MD, Lerner EA, 1996. Leishmaniasis. J Am Acad Dermatol 34: 257–272.
-
9.
Khandelwal K, Bumb RA, Mehta RD, Kaushal H, Lezama-Davila C, Salotra P, Satoskar AR, 2011. Case report: a patient presenting with diffuse cutaneous leishmaniasis (DCL) as a first indicator of HIV infection in India. Am J Trop Med Hyg 85: 64–65.
-
10.
Hooja S, Sharma B, Jindal A, Vyas N, 2014. First reported cases of diffuse cutaneous leishmaniasis in human immunodeficiency virus positive patients in Jaipur District of Rajasthan, India. Trop Parasitol 4: 50–52.
-
11.
Murray HW, Berman JD, Davies CR, Saravia NG, 2005. Advances in leishmaniasis. Lancet 366: 1561–1577.
-
12.
Kochar DK, Aseri S, Sharma BV, Bumb RA, Mehta RD, Purohit SK, 2000. The role of rifampicin in the management of cutaneous leishmaniasis. QJM 93: 733–737.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 2040 | 680 | 90 |
| Full Text Views | 500 | 391 | 1 |
| PDF Downloads | 97 | 32 | 1 |
Case Report: Diffuse Cutaneous Leishmaniasis Successfully Treated with a Combination of Oral Rifampicin and Fluconazole
Nidhi Yadav
Nidhi Yadav
ShriRam Yadav Skin Clinic, Narnaul, India;
Search for other papers by Nidhi Yadav in
Current site
Google Scholar
PubMed
Search for other papers by Nidhi Yadav in
Current site
Google Scholar
PubMed
Bhushan Madke
Bhushan Madke
Department of Dermatology, Venereology and Leprosy, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, India
Search for other papers by Bhushan Madke in
Current site
Google Scholar
PubMed
Search for other papers by Bhushan Madke in
Current site
Google Scholar
PubMed
ABSTRACT.
Diffuse cutaneous leishmaniasis (DCL) is a rare parasitic infection caused by the Leishmania species. Diffuse cutaneous leishmaniasis commonly presents as non-ulcerating papules and nodules over the face, neck, and arms. A middle-aged female presented with multiple nodular lesions on her face, neck, and chest region. Histopathology of the lesions showed multiple amastigotes, confirming the diagnosis of DCL. She was successfully treated with a combination course of rifampicin and fluconazole. Here, we report the first case of DCL in north India, a non-endemic area for cutaneous leishmaniasis.
Author Notes
Authors’ addresses: Nidhi Yadav, ShriRam Yadav Skin Clinic, Narnaul, India, E-mail: ny.invincible@gmail.com. Bhushan Madke, Department of Dermatology, Venereology and Leprosy, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, India, E-mail: drbhushan81@gmail.com.
ProCite
RefWorks
Reference Manager
BibTeX
Zotero
EndNote
-
1.
Burza S, Croft SL, Boelaert M, 2018. Leishmaniasis. Lancet 392: 951–970.
-
2.
Hashiguchi Y, Gomez EL, Kato H, Martini LR, Velez LN, Uezato H, 2016. Diffuse and disseminated cutaneous leishmaniasis: clinical cases experienced in Ecuador and a brief review. Trop Med Health 44: 2.
-
3.
Eiras DP, Kirkman LA, Murray HW, 2015. Cutaneous leishmaniasis: current treatment practices in the USA for returning travelers. Curr Treat Options Infect Dis 7: 52–62.
-
4.
Goto H, Lauletta Lindoso JA, 2012. Cutaneous and mucocutaneous leishmaniasis. Infect Dis Clin North Am 26: 293–307.
-
5.
Kumari A, Balai M, Gupta LK, Khare AK, Mittal AK, Mehta S, 2018. Diffuse cutaneous leishmaniasis in an immunocompromised patient resembling histoid Hansen’s disease. Indian Dermatol Online J 9: 452–454.
-
6.
Mariz BALA, Sánchez-Romero C, Alvarado NAP, Campos EMM, Almeida OP, MartÃnez-Pedraza R, 2019. Diffuse cutaneous leishmaniasis with oral involvement in a patient of Northern Mexico. Trop Doct 49: 303–306.
-
7.
Rahman H, Razzak MA, Chanda BC, Bhaskar KR, Mondal D, 2014. Cutaneous leishmaniasis in an immigrant Saudi worker: a case report. J Health Popul Nutr 32: 372–376.
-
8.
Suzanne A, Grevelink MD, Lerner EA, 1996. Leishmaniasis. J Am Acad Dermatol 34: 257–272.
-
9.
Khandelwal K, Bumb RA, Mehta RD, Kaushal H, Lezama-Davila C, Salotra P, Satoskar AR, 2011. Case report: a patient presenting with diffuse cutaneous leishmaniasis (DCL) as a first indicator of HIV infection in India. Am J Trop Med Hyg 85: 64–65.
-
10.
Hooja S, Sharma B, Jindal A, Vyas N, 2014. First reported cases of diffuse cutaneous leishmaniasis in human immunodeficiency virus positive patients in Jaipur District of Rajasthan, India. Trop Parasitol 4: 50–52.
-
11.
Murray HW, Berman JD, Davies CR, Saravia NG, 2005. Advances in leishmaniasis. Lancet 366: 1561–1577.
-
12.
Kochar DK, Aseri S, Sharma BV, Bumb RA, Mehta RD, Purohit SK, 2000. The role of rifampicin in the management of cutaneous leishmaniasis. QJM 93: 733–737.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 2040 | 680 | 90 |
| Full Text Views | 500 | 391 | 1 |
| PDF Downloads | 97 | 32 | 1 |